Evidence map›Paper›PMID 37672559›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Overcoming EGFR inhibitor resistance in Glioblastoma by targeting co-amplified genes.

Ayush Pant, Michael Lim

Open access · greenAbstract readEditorialComment
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Ayush PantDepartment of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, MD 21287.
Michael LimDepartment of Neurosurgery, School of Medicine, Stanford University, Stanford, CA 94304.
Johns Hopkins University · USStanford University · US

Funding

Medical Scientist Training ProgramT32GM136577 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI ANDREA L COX · 2020 to 2026
$13.4M
Targeting Lag-3 and PD -1 in Myeloid Cells of GBMR01NS121404 · NINDS · STANFORD UNIVERSITY · PI Michael Lim · 2022 to 2026
$2.0M
Generating a Systemic Immune Response Using Localized Delivery of Chemotherapy in Brain TumorsR01CA230285 · NCI · STANFORD UNIVERSITY · PI LIM, MICHAEL · 2019 to 2024
$1.8M
NCI NIH HHS R01 CA230285NIGMS NIH HHS T32 GM136577NINDS NIH HHS R01 NS121404
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GlioblastomaImmune System PhenomenaErbB ReceptorsHumansSEC Translocation ChannelsEGFR protein, humanErbB ReceptorsSEC61G protein, humanSEC Translocation Channels

Identifiers

PMID37672559
PMCPMC10515143
OpenAlexW4386470087

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.